The burden of
this collection is revised per 9/18 discussions with FDA. In
addition, this collection of information expired 2/29/96 and is
therefore a violation of the Paperwork Reduction Act. FDA should
take careful steps to ensure that such lapses in approval do not
occur in the future.
Inventory as of this Action
Requested
Previously Approved
09/30/2000
09/30/2000
2
0
0
69
0
0
1,395,000
0
0
The FDA has the statutory authority
under section 304(g) of the FD&C Act to detain devices during
establishment inspections, which are believed to be adulturated or
misbranded. On March 9, 1979, FDA issued a final regulation on
Administrative Detention Procedures which includes, among other
things, certain reporting and recordkeeping requirements. FDA also
has the statutory authority under section 516 of the Act to ban
devices that present substantial deception; unreasonable and
substantial risk of illness or injury; or unreasonable, direct, and
substantial danger to the health of individuals.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.